India’s Central Bank Targets $25 Billion Surge in Digital Fraud
, , ,

India’s Central Bank Targets $25 Billion Surge in Digital Fraud

India is facing a massive escalation in digital financial crimes, with losses reaching an estimated $25 billion in 2025. This figure represents a staggering 4,300% increase since 2021, highlighting the risks associated with the country’s rapid transition to a digital-first economy. Fraudsters have increasingly utilized sophisticated ‘social engineering’ tactics, creating a sense of urgency and […]

Bitcoin Retreats as Fed Maintains Interest Rates and Market Volatility Grows
, ,

Bitcoin Retreats as Fed Maintains Interest Rates and Market Volatility Grows

Bitcoin experienced a downward trend on Wednesday, briefly dipping below the $75,000 threshold as the Federal Reserve opted to keep interest rates unchanged. The decision to maintain current borrowing costs signaled a cautious approach toward monetary policy, effectively dampening investor optimism regarding near-term rate cuts. As a result, market participants shifted away from risk-sensitive assets, […]

U.S. Escalates Financial Pressure on Banks Linked to Iranian Oil Exports
, , , ,

U.S. Escalates Financial Pressure on Banks Linked to Iranian Oil Exports

The U.S. Treasury Department has issued a formal warning to global financial institutions regarding the severe sanctions risks associated with facilitating transactions for Chinese independent refineries. These smaller-scale facilities, often referred to as ‘teapot’ refineries, have become the primary destination for Iranian crude, with estimates suggesting China currently absorbs roughly 90% of Iran’s total oil […]

AstraZeneca and GSK Outperform Expectations Amid Global Pricing Volatility
, , , ,

AstraZeneca and GSK Outperform Expectations Amid Global Pricing Volatility

AstraZeneca and GSK have kicked off 2026 with financial performances that exceeded analyst projections, signaling resilience within the United Kingdom’s pharmaceutical sector. AstraZeneca reported core earnings of $2.58 per share, comfortably beating the $2.53 forecast, while GSK posted a core EPS of £0.47, surpassing expectations of £0.43. These results arrive at a critical juncture as […]